29 research outputs found
Dynamics of Higher Spin Fields and Tensorial Space
The structure and the dynamics of massless higher spin fields in various
dimensions are reviewed with an emphasis on conformally invariant higher spin
fields. We show that in D=3,4,6 and 10 dimensional space-time the conformal
higher spin fields constitute the quantum spectrum of a twistor-like particle
propagating in tensorial spaces of corresponding dimensions. We give a detailed
analysis of the field equations of the model and establish their relation with
known formulations of free higher spin field theory.Comment: JHEP3 style, 40 pages; v2 typos corrected, comments and references
added; v3 published versio
Nernst Effect and Anomalous Transport in Cuprates: A Preformed-Pair Alternative to the Vortex Scenario
We address those puzzling experiments in underdoped high
superconductors which have been associated with normal state "vortices" and
show these data can be understood as deriving from preformed pairs with onset
temperature . For uncorrelated bosons in small magnetic fields, and
arbitrary , we present the exact contribution to \textit{all}
transport coefficients. In the overdoped regime our results reduce to those of
standard fluctuation theories (). Semi-quantitative agreement
with Nernst, ac conductivity and diamagnetic measurements is quite reasonable.Comment: 9 pages, 4 figures; Title, abstract and contents modified, new
references added, figures changed, one more figure added; to be published on
PR
An assessment of Evans' unified field theory I
Evans developed a classical unified field theory of gravitation and
electromagnetism on the background of a spacetime obeying a Riemann-Cartan
geometry. This geometry can be characterized by an orthonormal coframe theta
and a (metric compatible) Lorentz connection Gamma. These two potentials yield
the field strengths torsion T and curvature R. Evans tried to infuse
electromagnetic properties into this geometrical framework by putting the
coframe theta to be proportional to four extended electromagnetic potentials A;
these are assumed to encompass the conventional Maxwellian potential in a
suitable limit. The viable Einstein-Cartan(-Sciama-Kibble) theory of gravity
was adopted by Evans to describe the gravitational sector of his theory.
Including also the results of an accompanying paper by Obukhov and the author,
we show that Evans' ansatz for electromagnetism is untenable beyond repair both
from a geometrical as well as from a physical point of view. As a consequence,
his unified theory is obsolete.Comment: 39 pages of latex, modified because of referee report, mistakes and
typos removed, partly reformulated, taken care of M.W.Evans' rebutta
QED3 theory of underdoped high temperature superconductors
Low-energy theory of d-wave quasiparticles coupled to fluctuating vortex
loops that describes the loss of phase coherence in a two dimensional d-wave
superconductor at T=0 is derived. The theory has the form of 2+1 dimensional
quantum electrodynamics (QED3), and is proposed as an effective description of
the T=0 superconductor-insulator transition in underdoped cuprates. The
coupling constant ("charge") in this theory is proportional to the dual order
parameter of the XY model, which is assumed to be describing the quantum
fluctuations of the phase of the superconducting order parameter. The principal
result is that the destruction of phase coherence in d-wave superconductors
typically, and immediately, leads to antiferromagnetism. The transition can be
understood in terms of the spontaneous breaking of an approximate "chiral"
SU(2) symmetry, which may be discerned at low enough energies in the standard
d-wave superconductor. The mechanism of the symmetry breaking is analogous to
the dynamical mass generation in the QED3, with the "mass" here being
proportional to staggered magnetization. Other insulating phases that break
chiral symmetry include the translationally invariant "d+ip" and "d+is"
insulators, and various one dimensional charge-density and spin-density waves.
The theory offers an explanation for the rounded d-wave-like dispersion seen in
ARPES experiments on Ca2CuO2Cl2 (F. Ronning et. al., Science 282, 2067 (1998)).Comment: Revtex, 20 pages, 5 figures; this is a much extended follow-up to the
Phys. Rev. Lett. vol.88, 047006 (2002) (cond-mat/0110188); improved
presentation, many additional explanations, comments, and references added,
sec. IV rewritten. Final version, to appear in Phys. Rev.
The global retinoblastoma outcome study : a prospective, cluster-based analysis of 4064 patients from 149 countries
DATA SHARING : The study data will become available online once all analyses are complete.BACKGROUND : Retinoblastoma is the most common intraocular cancer worldwide. There is some evidence to suggest that major differences exist in treatment outcomes for children with retinoblastoma from different regions, but these differences have not been assessed on a global scale. We aimed to report 3-year outcomes for children with retinoblastoma globally and to investigate factors associated with survival. METHODS : We did a prospective cluster-based analysis of treatment-naive patients with retinoblastoma who were diagnosed between Jan 1, 2017, and Dec 31, 2017, then treated and followed up for 3 years. Patients were recruited from 260 specialised treatment centres worldwide. Data were obtained from participating centres on primary and additional treatments, duration of follow-up, metastasis, eye globe salvage, and survival outcome. We analysed time to death and time to enucleation with Cox regression models. FINDINGS : The cohort included 4064 children from 149 countries. The median age at diagnosis was 23·2 months (IQR 11·0–36·5). Extraocular tumour spread (cT4 of the cTNMH classification) at diagnosis was reported in five (0·8%) of 636 children from high-income countries, 55 (5·4%) of 1027 children from upper-middle-income countries, 342 (19·7%) of 1738 children from lower-middle-income countries, and 196 (42·9%) of 457 children from low-income countries. Enucleation surgery was available for all children and intravenous chemotherapy was available for 4014 (98·8%) of 4064 children. The 3-year survival rate was 99·5% (95% CI 98·8–100·0) for children from high-income countries, 91·2% (89·5–93·0) for children from upper-middle-income countries, 80·3% (78·3–82·3) for children from lower-middle-income countries, and 57·3% (52·1-63·0) for children from low-income countries. On analysis, independent factors for worse survival were residence in low-income countries compared to high-income countries (hazard ratio 16·67; 95% CI 4·76–50·00), cT4 advanced tumour compared to cT1 (8·98; 4·44–18·18), and older age at diagnosis in children up to 3 years (1·38 per year; 1·23–1·56). For children aged 3–7 years, the mortality risk decreased slightly (p=0·0104 for the change in slope). INTERPRETATION : This study, estimated to include approximately half of all new retinoblastoma cases worldwide in 2017, shows profound inequity in survival of children depending on the national income level of their country of residence. In high-income countries, death from retinoblastoma is rare, whereas in low-income countries estimated 3-year survival is just over 50%. Although essential treatments are available in nearly all countries, early diagnosis and treatment in low-income countries are key to improving survival outcomes.The Queen Elizabeth Diamond Jubilee Trust and the Wellcome Trust.https://www.thelancet.com/journals/langlo/homeam2023Paediatrics and Child Healt
Global Retinoblastoma Presentation and Analysis by National Income Level
Importance: Early diagnosis of retinoblastoma, the most common intraocular cancer, can save both a child's life and vision. However, anecdotal evidence suggests that many children across the world are diagnosed late. To our knowledge, the clinical presentation of retinoblastoma has never been assessed on a global scale. Objectives: To report the retinoblastoma stage at diagnosis in patients across the world during a single year, to investigate associations between clinical variables and national income level, and to investigate risk factors for advanced disease at diagnosis. Design, Setting, and Participants: A total of 278 retinoblastoma treatment centers were recruited from June 2017 through December 2018 to participate in a cross-sectional analysis of treatment-naive patients with retinoblastoma who were diagnosed in 2017. Main Outcomes and Measures: Age at presentation, proportion of familial history of retinoblastoma, and tumor stage and metastasis. Results: The cohort included 4351 new patients from 153 countries; the median age at diagnosis was 30.5 (interquartile range, 18.3-45.9) months, and 1976 patients (45.4) were female. Most patients (n = 3685 84.7%) were from low-and middle-income countries (LMICs). Globally, the most common indication for referral was leukocoria (n = 2638 62.8%), followed by strabismus (n = 429 10.2%) and proptosis (n = 309 7.4%). Patients from high-income countries (HICs) were diagnosed at a median age of 14.1 months, with 656 of 666 (98.5%) patients having intraocular retinoblastoma and 2 (0.3%) having metastasis. Patients from low-income countries were diagnosed at a median age of 30.5 months, with 256 of 521 (49.1%) having extraocular retinoblastoma and 94 of 498 (18.9%) having metastasis. Lower national income level was associated with older presentation age, higher proportion of locally advanced disease and distant metastasis, and smaller proportion of familial history of retinoblastoma. Advanced disease at diagnosis was more common in LMICs even after adjusting for age (odds ratio for low-income countries vs upper-middle-income countries and HICs, 17.92 95% CI, 12.94-24.80, and for lower-middle-income countries vs upper-middle-income countries and HICs, 5.74 95% CI, 4.30-7.68). Conclusions and Relevance: This study is estimated to have included more than half of all new retinoblastoma cases worldwide in 2017. Children from LMICs, where the main global retinoblastoma burden lies, presented at an older age with more advanced disease and demonstrated a smaller proportion of familial history of retinoblastoma, likely because many do not reach a childbearing age. Given that retinoblastoma is curable, these data are concerning and mandate intervention at national and international levels. Further studies are needed to investigate factors, other than age at presentation, that may be associated with advanced disease in LMICs. © 2020 American Medical Association. All rights reserved